uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Idhifa
Application withdrawn
Human
Details
EMA number
EMEA/H/C/004324
ATC code
L01XX
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of acute myeloid leukaemia (AML)
MeSH:
Leukemia, Myeloid, Acute
Group:
Antineoplastic agents
Marketing Authorisation Holder
Celgene Europe BV
MAH
Idhifa | uMedical